News
The S&P 500 rose by 0.52% on Friday to close at a record high of 6,173.07, marking returns of 3.44% for the week, as traders looked past the termination of trade talks between the United States and ...
Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.
GAMMA Investing LLC increased its stake in Eli Lilly by 25.8%, now holding 18,000 shares valued at nearly $15 million. This ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...
The stock's fall snapped a four-day winning streak.
Eli Lilly faces market headwinds, slowing growth, and rising competition. Discover why now might be the time for LLY ...
Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing ...
Altimmune’s GLP-1/glucagon dual receptor agonist achieved a hit and a miss when it came to the dual goals of a phase 2 ...
Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.
Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results